Abivax (ABVX) Non-Current Assets (2021 - 2026)

Abivax's Non-Current Assets history runs 6 years deep, the most recent figure standing at $39.7 million for Q1 2026.

• On a quarterly basis, Non-Current Assets rose 10.16% year-over-year to $39.7 million in Q1 2026; TTM through Mar 2026 was $39.7 million, a 10.16% increase from a year earlier, with the FY2025 full-year figure at $38.5 million, up 3.0% from the prior year.
• Non-Current Assets climbed to $39.7 million in Q1 2026 per ABVX's latest filing, from $38.5 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $44.7 million in Q2 2024 and bottomed at $36.1 million in Q1 2025.
• The 5-year median for Non-Current Assets is $38.5 million (2025), against an average of $39.6 million.
• Across the five-year window, Non-Current Assets dropped 16.47% in 2024 and gained 10.16% in 2026, its largest moves.
• Year by year, Non-Current Assets stood at $40.2 million in 2022, then grew by 10.09% to $44.2 million in 2023, then slipped by 16.47% to $36.9 million in 2024, then rose by 4.33% to $38.5 million in 2025, then grew by 3.08% to $39.7 million in 2026.
• Per Business Quant, the three latest ABVX Non-Current Assets figures stand at $39.7 million (Q1 2026), $38.5 million (Q4 2025), and $38.3 million (Q3 2025).